Recruiting

Social Prescribing for a Mindful Lifestyle

I'm interested View official listing

ClinicalTrials.gov IDNCT07669805

PhaseNA

Enrollment50

SponsorBuddhist Tzu Chi General Hospital

Age55 Years and older

SexALL

I'm interested View official listing

Conditions studied

Depression and/or Anxiety in the Mild-to-moderate Range, Loneliness, Social Isolation

About this study

The goal of this clinical trial is to evaluate the effectiveness of an 8-week mindfulness lifestyle social prescribing program in community-dwelling older adults aged 55 and older. The main questions it aims to answer are: To establish a mindfulness lifestyle social prescribing model applied to the psychological and social health promotion of middle-aged and older populations. To evaluate the effectiveness of the intervention on improving depressive symptoms, loneliness, and quality of life in this population. Participants will receive an 8-week group intervention program, with each weekly session lasting approximately 3 hours. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). Researchers will collect and evaluate data from pre- and post-intervention assessments to measure changes in depressive symptoms, loneliness risk, and overall quality of life.

Interventions

Behavioral: Mindfulness Lifestyle Social Prescribing Program — An 8-week, once-weekly, 3-hour group program designed for middle-aged and older adults. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). It is delivered by a multidisciplinary team including geriatricians, case managers, dietitians, exercise instructors, and volunteers.

Primary outcomes

Changes in Geriatric Depression Scale (GDS-15) score (Baseline and Week 8)
Changes in UCLA Loneliness Scale score (Baseline and Week 8)
Changes in WHOQOL-BREF questionnaire score (Baseline and Week 8)

Eligibility information

Inclusion Criteria: * People aged 55 years or older. * People with a Geriatric Depression Scale (GDS-15) score of 7-10 or a UCLA Loneliness Scale Version 3 score of 35-64. * People can understand the research process, meet the requirements of the research, and can sign the informed consent and participate in the project. Exclusion Criteria: * People that are unable to cooperate with the project or follow-up. * According to the PI's judgment, people with severe or poorly controlled conditions include ongoing acute diseases, severe infections, severe abnormal laboratory tests, or serious medical conditions with the following systems: cardiovascular, pulmonary, hepatic, nervous, mental, metabolic, renal, musculoskeletal, gastrointestinal, etc. * People with severe depression, risk of self-harm, severe cognitive impairment (dementia), visual or hearing impairment, and disabilities that prevent the completion of the project and assessment. * People are currently or expected to join any other physical training courses or nutrition intervention plans during the project period. * Others are based on the judgment of the PI that participating in this project may adversely affect the safety of the subjects, hinder the progress of the experiment, or interfere with the evaluation of the outcomes of the project.

Study locations

Buddhist Tzu Chi General Hospital, Hualien City, Taiwan 97071 Taiwan

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-12.